CORONAVIRUS (COVID-19)-Plans for the next academic year.
The teaching staff are now beginning to return to the School to resume their academic activities. They are working at a pace to change the way we deliver our courses. Moving forward, we will be using blended and e-learning methods. We aim to roll out the modules, which were postponed during the initial stages of COVID-19, in a phased approach, starting in September 2020, over an eight-month period. This is in line with Health Education England (HEE) who have proposed an extension to the education contract period. This is to allow time for the recovery of commissions that were postponed due to the pandemic.
As you will recognise because of COVID-19, plans are constantly changing so we will, as the situation evolves, endeavour to keep you informed. The health and wellbeing of our staff and students are our absolute priority.
If you do have any questions or concerns, please refer to our Student Q&A page or contact us at Student Support Services for more information.
Delivery method
Face to face
Duration
3 years part-time
Academic credits and level
180 credits at level 7
Start date
Postponed due to COVID-19
Pathway structure
All modules are 15 credits unless otherwise stated
Pathway summary
This master's level pathway is intended to enable health professionals working with cancer patients to critically explore the evidence base for practice. Students can tailor the programme to their clinical interests by choosing from a wide range of specialist modules.
You can apply for modules on the programme on a stand-alone basis. If successful these will be added to your programme when you enrol.
This pathway is in association with:
